Tag: Weight Loss

Clinical trial demonstrates reduction in major adverse cardiovascular events of 20 percent, drug maker says

Lawsuit alleges drugmakers failed to adequately warn patients about the risk for severe stomach problems

No change in cardiometabolic risk factors or glycemic control seen over six months

Three case reports from Iceland spurred the review; two of the cases involved Ozempic

Substantial reductions seen in body weight with retatrutide treatment for 48 weeks in phase 2 trial

Substantial and clinically meaningful reductions in body weight seen for adults with obesity and type 2 diabetes

Superior and clinically meaningful reduction in body weight in adults with overweight, obesity without type 2 diabetes

Weight reduction of at least 10 percent occurred in 46 to 75 percent receiving orforglipron by week 36

However, weight loss by 12 months was not significantly different for time-restricted eating, calorie restriction

Company has moved to stop some medical spas, weight loss clinics, and compounding pharmacies from selling compounded versions of semaglutide